Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

 Department of Clinical Medicine M-lab Publications

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Glorieux, F. H., Langdahl, B., Chapurlat, R., De Beur, S. J., Sutton, V. R., Poole, K. E. S., Dahir, K. M., Orwoll, E. S., Willie, B. M., Mikolajewicz, N., Zimmermann, E., Hosseinitabatabaei, S., Ominsky, M. S., Saville, C., Clancy, J., Mackinnon, A., Mistry, A. & Javaid, M. K. (2024). Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study. Journal of Bone and Mineral Research (JBMR), 39(9), 1215-1228. https://doi.org/10.1093/jbmr/zjae112
Gopalasingam, N., Moeslund, N., Christensen, K. H., Berg-Hansen, K., Seefeldt, J., Homilius, C., Nielsen, E. N., Dollerup, M. R., Alstrup Olsen, A. K., Johannsen, M., Boedtkjer, E., Møller, N., Eiskjær, H., Gormsen, L. C., Nielsen, R. & Wiggers, H. (2024). Enantiomer-Specific Cardiovascular Effects of the Ketone Body 3-Hydroxybutyrate. Journal of the American Heart Association, 13(8), e033628. Article e033628. https://doi.org/10.1161/JAHA.123.033628
Gopalasingam, N., Berg-Hansen, K., Christensen, K. H., Ladefoged, B. T., Poulsen, S. H., Andersen, M. J., Borlaug, B., Nielsen, R., Møller, N. & Wiggers, H. (2024). Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Circulation, 150(20), 1570-1583. https://doi.org/10.1161/CIRCULATIONAHA.124.069732
Grauslund, J., Stokholm, L., Andersen, N., Andresen, J., Bek, T., Knudsen, S. T. & Subhi, Y. (2024). Risk of 2-year progression from no diabetic retinopathy to proliferative diabetic retinopathy in accordance with glycaemic regulation in 145 527 persons with diabetes in a national cohort. Acta Ophthalmologica, 102(3), e407-e409. https://doi.org/10.1111/aos.15806
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., Klein, K. O., Prakash, S. K., Kanakatti Shankar, R., Sandberg, D. E., Sas, T. C. J., Skakkebæk, A., Stochholm, K., van der Velden, J. A., Backeljauw, P. F. & International Turner Syndrome Consensus Group (2024). Clinical Practice Guidelines for the Care of Girls and Women with Turner Syndrome. European Journal of Endocrinology, 190(6), G53-G151. https://doi.org/10.1093/ejendo/lvae050
Gribsholt, S. B., Szépligeti, S. K., Sørensen, H. T., Mueller, N. T., Karagas, M. R. & Ehrenstein, V. (2024). Prenatal and Early-Life Anti-Infectives and Obesity at Age 7 Years. Pharmacoepidemiology and Drug Safety, 33(11), Article e70055. https://doi.org/10.1002/pds.70055
Gribsholt, S. B., Schmidt, M., Kristiansen, E. B., Richelsen, B. & Sørensen, H. T. (2024). Risk of cardiovascular disease after hospital-diagnosed overweight or obesity. Endocrine Connections, 13(4), Article e230452 . https://doi.org/10.1530/EC-23-0452
Grove-Laugesen, D., Ebbehoj, E., Watt, T., Hansen, K. W. & Rejnmark, L. (2024). Changes in bone density and microarchitecture following treatment of Graves’ disease and the effects of vitamin D supplementation. A randomized clinical trial. Osteoporosis International, 35(12), 2153-2164. https://doi.org/10.1007/s00198-024-07241-y
Gude, M. (2024). IGF1 and its regulatory proteins, including PAPP-A and STC2, in atherosclerosis and cardiovascular disease. [PhD dissertation, Aarhus University].
Gude, M. F., Hjortebjerg, R., Bjerre, M., Pedersen, A. K. N., Oxvig, C., Rasmussen, L. M., Frystyk, J. & Steffensen, L. (2024). The pro-atherogenic enzyme PAPP-A is active in eluates from human carotid and femoral atherosclerotic plaques. Atherosclerosis Plus, 57, 30-36. https://doi.org/10.1016/j.athplu.2024.09.001

Displaying results 511 to 520 out of 4018

Previous

48

49

50

51

52

53

54

55

56

57

Next

Revised 11.09.2025
-
Department of Clinical Medicine